As of May 27
| +0.41 / +0.62%|
The 18 analysts offering 12-month price forecasts for LifePoint Health Inc have a median target of 75.00, with a high estimate of 94.00 and a low estimate of 61.50. The median estimate represents a +12.88% increase from the last price of 66.44.
The current consensus among 23 polled investment analysts is to Hold stock in LifePoint Health Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.